Psychometric Validation of the "Antillanisée" Version of the Mini Mental State Examination (MMSEa)

NCT03324711 | Terminated

• 1 other identifier: 15/B/26
• Study Type: interventional
• Target: 75
• Locations: 1 country
• Sites: 1

Brief Summary

The main objective of the study is to analyze the psychometric properties of the "antillanisée" version of the Mini Mental State Examination (MMSEa). The methodology used will permit to explore the feasibility, acceptability, validity and reliability of the tool. The psychometric validation of a version adapted transculturally will increase the value of the results obtained with this test and will make it possible to refine the screening of existing cognitive disorders for elderly subjects with Alzheiner's disease or related disorders.

Conditions

Elderly Patients; Cognitive Disorder; Alzheimer Disease

Keywords

Cognitive disorders; Alzheimer's disease; Mini Mental State Examination; Geriatry

Outcome Measures

Primary Outcomes (1)

• Evaluation of the psychometric properties of the questionnaire MMSEa

  The following will be measured: * feasibility and acceptability; * validity of structure; * discriminant validity; * predictive validity; * validity of convergence; * reliability (internal consistency,reproducibility (test-retest)).

  12 month (+/- 15 days)

Secondary Outcomes (1)

• Evaluation of the psychometric properties of questionnaire SPPB

  12 month (+/- 15 days)

Study Arms (1)

Elderly patient (65 and more)

OTHER

Ederly patients seen in geriatric day hospital, from creole culture.

Diagnostic Test: "Antillanisée" Mini Mental State Examination (MMSEa)

Interventions

"Antillanisée" Mini Mental State Examination (MMSEa) DIAGNOSTIC_TEST

"Antillanisée" version of the Mini Mental State Examination (MMSEa), is a version adaptated to the French West Indies creole culture.

Also known as: MMSEa

Elderly patient (65 and more)

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• Subject of 65 years old and over
• Subject admitted in a geriatric day hospital
• Patients of creole culture
• Subject having French and/or Creole as mother tongue
• Subject able to undergo neuropsychological tests
• Subject having given informed consent or, informed consent given by his or her primary caregiver
• Subject affiliated to a social security scheme

You may not qualify if:

• Subject with a disability seriously compromising oral communication (understanding and expression)
• Subject with behavioral disorder that does not allow for testing
• Subject in general condition not allowing its participation in the tests

Sponsors & Collaborators

• University Hospital Center of Martinique: lead

Study Sites (1)

CHU de Martinique

Fort-de-France, Martinique, 97200, France

Location

MeSH Terms

Conditions

Cognitive Dysfunction; Alzheimer Disease

Condition Hierarchy (Ancestors)

Cognition Disorders; Neurocognitive Disorders; Mental Disorders; Dementia; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Tauopathies; Neurodegenerative Diseases

Study Officials

• Lidvine GODAERT-SIMON, MD

  CHU of Martinique

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 11, 2017
• First Posted: October 30, 2017
• Study Start: November 15, 2016
• Primary Completion: April 11, 2019
• Study Completion: July 1, 2019
• Last Updated: March 9, 2022

Record last verified: 2022-02

Locations

FR (1)